# Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

> **NCT06214819** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Fundación EPIC** · enrollment: 40 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** VIVO ISAR DES implanted in the First lesion, XIENCE Skypoint DES implanted in the Second lesion
- **DEVICE:** XIENCE Skypoint DES implanted in the First lesion, VIVO ISAR DES implanted in the Second lesion

## Key facts

- **NCT ID:** NCT06214819
- **Lead sponsor:** Fundación EPIC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-20
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-08-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06214819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06214819, "Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06214819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*